• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Going Beyond Antiarrhythmic-Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient.

作者信息

Reiffel James A

机构信息

Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University, New York, NY, USA.

出版信息

J Innov Card Rhythm Manag. 2019 Mar 15;10(3):3561-3563. doi: 10.19102/icrm.2019.100301. eCollection 2019 Mar.

DOI:10.19102/icrm.2019.100301
PMID:32496477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252843/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c33a/7252843/da9e009db34f/icrm-10-3561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c33a/7252843/da9e009db34f/icrm-10-3561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c33a/7252843/da9e009db34f/icrm-10-3561-g001.jpg

相似文献

1
Going Beyond Antiarrhythmic-Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient.超越抗心律失常药与抗凝药的药物相互作用：复杂用药患者的考量
J Innov Card Rhythm Manag. 2019 Mar 15;10(3):3561-3563. doi: 10.19102/icrm.2019.100301. eCollection 2019 Mar.
2
Clinically Important Drug-Drug Interactions Between Antiarrhythmic Drugs and Anticoagulants.抗心律失常药物与抗凝剂之间临床上重要的药物相互作用。
J Innov Card Rhythm Manag. 2019 Mar 15;10(3):3552-3559. doi: 10.19102/icrm.2019.100304. eCollection 2019 Mar.
3
Previous therapy with amiodarone increases the recurrence rate in successfully ablated patients with isthmus-dependent atrial flutter.既往使用胺碘酮治疗会增加峡部依赖性心房扑动成功消融患者的复发率。
Rev Port Cardiol. 2004 Oct;23(10):1303-11.
4
Potentially significant drug interactions of class III antiarrhythmic drugs.III类抗心律失常药物潜在的显著药物相互作用。
Drug Saf. 2003;26(6):421-38. doi: 10.2165/00002018-200326060-00004.
5
The impact of pre-injury anticoagulation therapy in the older adult patient experiencing a traumatic brain injury: A systematic review.伤前抗凝治疗对老年创伤性脑损伤患者的影响：一项系统综述。
JBI Libr Syst Rev. 2012;10(58):4610-4621. doi: 10.11124/jbisrir-2012-429.
6
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era.新型口服抗凝剂时代静脉血栓栓塞症患者长期抗凝治疗的考量
Vasc Health Risk Manag. 2016 Feb 10;12:23-34. doi: 10.2147/VHRM.S88088. eCollection 2016.
7
The influence of pre-operative antiplatelet and anticoagulant agents on the outcomes in elderly patients undergoing early surgery for hip fracture.术前抗血小板和抗凝药物对老年髋部骨折早期手术患者预后的影响。
J Orthop Sci. 2019 Sep;24(5):830-835. doi: 10.1016/j.jos.2018.12.027. Epub 2019 Jan 30.
8
Antiarrhythmic drug interactions: are they important?抗心律失常药物相互作用：它们重要吗？
Eur Heart J. 1987 Mar;8 Suppl A:127-32. doi: 10.1093/eurheartj/8.suppl_a.127.
9
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy.心房颤动与人类免疫缺陷病毒 1 型感染：系统评价。对抗凝和抗心律失常治疗的影响。
Br J Clin Pharmacol. 2019 Mar;85(3):508-515. doi: 10.1111/bcp.13837. Epub 2019 Jan 11.
10
Medicated chewing gum, a novel drug delivery system.药用口香糖，一种新型药物递送系统。
J Res Med Sci. 2015 Apr;20(4):403-11.

引用本文的文献

1
"Ranolaziodarone"-A Synergism You Should Not Miss.“雷诺唑胺与胺碘酮联用”——一种不容错过的协同作用
J Innov Card Rhythm Manag. 2021 Mar 15;12(3):4429-4431. doi: 10.19102/icrm.2021.120303. eCollection 2021 Mar.

本文引用的文献

1
Clinically Important Drug-Drug Interactions Between Antiarrhythmic Drugs and Anticoagulants.抗心律失常药物与抗凝剂之间临床上重要的药物相互作用。
J Innov Card Rhythm Manag. 2019 Mar 15;10(3):3552-3559. doi: 10.19102/icrm.2019.100304. eCollection 2019 Mar.
2
Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.非维生素K口服抗凝药联合或不联合同时使用的药物与非瓣膜性心房颤动患者大出血风险之间的关联
JAMA. 2017 Oct 3;318(13):1250-1259. doi: 10.1001/jama.2017.13883.
3
Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.
多重用药与死亡率：来自一大群老年人的新见解，通过检测多重疾病的效应修正和按指征全面校正混杂因素
Eur J Clin Pharmacol. 2017 Aug;73(8):1041-1048. doi: 10.1007/s00228-017-2266-7. Epub 2017 May 24.
4
Multi-Morbidity in Hospitalised Older Patients: Who Are the Complex Elderly?住院老年患者的多重疾病：谁是复杂老年人？
PLoS One. 2015 Dec 30;10(12):e0145372. doi: 10.1371/journal.pone.0145372. eCollection 2015.
5
Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.P-糖蛋白在达比加群、利伐沙班和阿哌沙班预防卒中中的相关性。
Herz. 2015 Apr;40 Suppl 2:140-5. doi: 10.1007/s00059-014-4188-9. Epub 2015 Jan 25.
6
Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey.发病率和多重发病率的常见模式及其对健康相关生活质量的影响：一项全国性调查的证据
Qual Life Res. 2015 Apr;24(4):909-18. doi: 10.1007/s11136-014-0820-7. Epub 2014 Oct 26.
7
Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.胺碘酮、抗凝治疗与心房颤动患者的临床事件：来自 ARISTOTLE 试验的见解。
J Am Coll Cardiol. 2014 Oct 14;64(15):1541-50. doi: 10.1016/j.jacc.2014.07.967.
8
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial.接受口服抗凝治疗的房颤患者抗心律失常治疗的应用及结果：ROCKET AF试验的结果
Heart Rhythm. 2014 Jun;11(6):925-32. doi: 10.1016/j.hrthm.2014.03.006. Epub 2014 May 13.
9
Patterns and expenditures of multi-morbidity in an insured working population in the United States: insights for a sustainable health care system and building healthier lives.美国参保工作人群中多种疾病的模式和支出：对可持续医疗保健系统和建设更健康生活的启示。
Popul Health Manag. 2013 Dec;16(6):381-9. doi: 10.1089/pop.2012.0068. Epub 2013 Aug 22.
10
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动。
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.